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Abstract 
Background: Few studies focus on pediatric thyroid nodules categorized under indeterminate 
diagnostic categories. The current study was conducted to assess the risk of malignancy of 
indeterminate pediatric thyroid nodules. 
Methods: A search of the institutional electronic pathology database from 01/2011 to 09/2018 
was performed to identify pediatric (< 21 years old) thyroid nodules which were interpreted as 
follicular lesion of undetermined significance (FLUS), suspicious for follicular neoplasm (SFN) 
or suspicious for malignancy (SFM) and subsequently managed with surgery, repeat FNA, or ≥ 6 
months of clinical/imaging monitoring. Results of follow-up (F/U) surgical resections and repeat 
FNA/Afirma tests, and clinical and radiologic data were collected. 
Results: We identified 46 cases from 42 patients (11 to 20 years old, 33 females and 9 males), 
including 30 FLUS, 10 SFN and 6 SFM. Twenty-five FLUS, 10 SFN and 6 SFM cases 
underwent surgery. The histology revealed carcinomas in 36% of FLUS, 20% of SFN, and 100% 
of SFM categories; follicular adenomas in 32% of FLUS and 80% of SFN categories; and benign 
nodules in 32% of FLUS category. All 5 non-surgically treated FLUS cases were considered 
benign based on the findings of repeat FNA/Afirma tests (n=3, 3-22 months F/U) or 
clinical/radiologic exams (n=2, 8-12 months F/U). 
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Conclusions: Based on a limited study cohort, malignancy was identified in 36%, 20% and 100% 
of surgically managed pediatric thyroid nodules categorized as FLUS, SFN and SFM, 
respectively; suggesting a markedly higher malignant rate than the implied malignant risk for 
FLUS and SFM categories in adults.   
 
Key words: Pediatric thyroid nodule, follicular lesion of undetermined significance, follicular 
neoplasm/suspicious for follicular neoplasm, suspicious for malignancy, risks of malignancy 
 
Introduction 
Although thyroid nodules are less common in children than adults, an overview of the literature 
has showed that pediatric thyroid nodules are more likely to be malignant and carry a 1.6 fold 
higher cancer risk compared to that of adult population.(1) The Management Guidelines for 
Children with Thyroid Nodules and Differentiated Thyroid Cancer from The American Thyroid 
Association recommends fine needle aspiration (FNA) as an essential tool for the assessment and 
management of pediatric thyroid nodules, and utilizing The Bethesda System for Reporting 
Thyroid Cytopathology (TBSRTC) as a guideline to categorize FNA cytologic findings.(2, 3) 
Among the six categories of TBSRTC, three are considered indeterminate, namely atypia of 
undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), follicular 
neoplasm/suspicious for follicular neoplasm (FN/SFN) and suspicious for malignancy (SFM). In 
spite of many published studies on cytologic, histologic and molecular findings of adult 
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indeterminate thyroid nodules, there are few publications focusing on pediatric thyroid nodules 
categorized under the indeterminate diagnostic categories of TBSRTC. The current study was 
conducted to assess the risk of malignancy and/or outcomes of pediatric thyroid nodules 
interpreted as indeterminate using TBSRTC criteria at a single center. 
 
Methods 
The retrospective study was approved by the Institutional Review Board (IRB) of the University 
of Michigan. A search of the Michigan Medicine institutional electronic pathology database from 
01/2011 to 09/2018 was performed to identify pediatric (< 21 years old) thyroid nodules which 
were previously aspirated and interpreted as FLUS, SFN or SFM, and subsequently managed 
with surgery, repeat FNA, or ≥ 6 months of clinical/imaging monitoring. Interventional 
radiologists performed ultrasound-guided FNAs with cytopathologist-assisted rapid on-site 
evaluation (ROSE). Briefly, two conventional smears were made for each pass. One smear was 
air-dried and stained with Diff-Quik protocol to be evaluated immediately for specimen 
adequacy while the other smear was fixed with SprayfixTM  and subsequently stained with 
Papanicolaou stain. The needle was then rinsed in Cytolyt solution for a ThinPrep or a cell block. 
When repeat FNA was performed in nodules previously interpreted as FLUS, additional passes 
may be collected for Afirma testing at the treating clinician’s discretion. For each case, age and 
gender of the patient, size of the targeted nodule, number of passes, and original cytologic 
interpretation were recorded. Further, results of subsequent surgical resections, repeat FNA, and 
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Afirma testing, as well as clinical and follow-up (F/U) radiologic data were collected. Re-review 
of slides prepared from the follow-up surgical specimens was performed to identify the cases that 
fulfilled the newly published diagnostic criteria of non-invasive follicular thyroid neoplasm with 
papillary-like nuclear features (NIFTP).(4)  
 
Results  
We identified a total of 46 cases from 42 patients with the average age of 15.1 years old (11 to 
20 years old), including 33 females and 9 males. The original cytologic interpretations included 
30 FLUS, 10 SFN and 6 SFM. Twenty-five FLUS, 10 SFN, and 6 SFM cases underwent surgery. 
Hemi-thyroidectomies were performed in 14 FLUS and 8 SFN cases while total thyroidectomies 
were performed in 11 FLUS, 2 SFN, and 5 SFM cases; one FLUS case and one SFM case 
underwent lobectomy followed by completion thyroidectomy. As can be seen in Table 1, the 
surgical specimens revealed malignancy in 9 of 25 (36%) FLUS, 2 of 10 (20%) SFN, and 6 of 6 
(100%) SFM categories; Follicular adenomas were identified in 8 of 25 FLUS (32%) and 8 of 10 
(80%) SFN categories. Benign nodules were diagnosed in 8 of 25 (32%) FLUS cases. Papillary 
thyroid carcinoma (PTC) represents the majority of malignancy (15/17), including 10 
conventional and 5 follicular variants (Figures 1-3) and all were managed by total 
thyroidectomy. The remaining 2 malignant cases were diagnosed as Hurthle cell carcinomas, one 
received hemithyroidectomy while the other one was treated with hemithyroidectomy followed 
by completion thyroidectomy. Re-review of the surgical specimens did not identify any cases 
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which fulfilled the diagnostic criteria of NIFTP and could be reclassified as such.(4) Among the 
25 surgically-treated FLUS cases, 2 received Afirma testing preoperatively and one patient was 
aspirated once while the other patient was aspirated twice with repeat FLUS categorization. 
Afirma testing in both 2 cases was interpreted as suspicious and the corresponding histologic 
examination revealed benign nodular hyperplasia in one patient and follicular variant of PTC in 
the other patient. Three out of the five non-surgically treated FLUS cases underwent repeat FNA 
which were interpreted as lymphocytic thyroiditis, nodular hyperplasia, and FLUS following 15 
months, 22 months and 3 months of follow-up, respectively; the concurrent Afirma testing in the 
repeat FLUS case was interpreted as benign. The findings of clinical and/or radiologic follow up 
(8-12 months) were considered benign in the remaining 2 non-surgically managed cases. Overall, 
malignancy was identified in 30%, 20% and 100% of pediatric thyroid nodules categorized as 
FLUS, SFN and SFM, respectively. 
 
Discussions 
FNA as an important tool in the cytologic assessment of pediatric thyroid nodules, provides 94% 
sensitivity, 81% specificity and 77.2-98.6% diagnostic accuracy.(5) Similar to the management 
of adult thyroid nodules, the real challenge is identification of malignancy among the 
indeterminate categories. Based on the first edition of TBSRTC, the implied risk of malignancy 
was 10-30%, 25-40% and 50-75% for AUS/FLUS, FN/SFN and SFM category, respectively.(3) 
In the most recently published edition of TBSRTC, the implied risk of malignancy for the 
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indeterminate categories has been modified as a result of introduction of the new diagnostic 
terminology ”non-invasive follicular neoplasm with papillary thyroid nuclear features 
(NIFTP)”.(4) Accordingly, the newly implied risks of malignancy are  6-18%, 10-40% and 45-
60% for AUS/FLUS, FN/SFN and SFM categories, respectively.(6) It is noteworthy to mention 
that the these results were generated from the adult population.  
In our current study, all nodules categorized as SFN and SFM underwent surgeries. The 
corresponding histology demonstrated carcinomas in all SFM cases and 20% of SFN cases. The 
majority (25/30) of the FLUS cases underwent surgeries and benign non-neoplastic nodules, 
follicular adenoma and carcinomas (PTC or Hurthle cell carcinoma) were confirmed in 8, 8, and 
9 cases, respectively. Re-review of the surgical specimens did not identify any cases which 
fulfilled the diagnostic criteria of NIFTP and could be reclassified as such. The remaining 5 non-
surgically treated FLUS cases were considered benign based on the results of repeat FNA, 
Afirma testing, and/or clinical/radiological findings. Taken together, FLUS, SFN and SFM 
categories had a malignant rate of 30%, 20% and 100%, respectively in our investigation.  It 
appears that pediatric indeterminate thyroid nodules, particularly nodules categorized as SFM 
and FLUS, carry a greater risk of malignancy than that of adult population after excluding 
NIFTP from malignant category. However, while interpreting these differences, one should note 
possible selection or sampling bias due to the limited pediatric case cohort contained in the 
current study. Although NIFTP has not been thoroughly investigated yet in pediatric patients, 
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this study and that of Rossi, et al which demonstrated that NIFTP comprised only 1.9% of 
resected pediatric thyroid nodules,(7) suggest that NIFTP in the pediatric population is rare.   
There is limited data on histology-confirmed malignancy within indeterminate categories from 
other institutions (Table 2).(8-14) Similarly to our data, all these previously published studies 
contained limited number of cases in each of the indeterminate categories, i.e. 4 to 25 cases in 
AUS/FLUS, 4 to 19 cases in FN/SFN, and 2 to 6 cases in SFM category. The majority of the 
studies from the other institutions demonstrated 100% of malignant rate in SFM category. The 
risk of malignancy for FLUS (36%) and SFN (20%) observed in our study falls within the ranges 
documented by other institutions, namely 8-50% for AUS/FLUS and 10-100% for FN/SFN 
category. In contrast with our finding that FLUS category carried a higher malignant rate than 
SFN category, a greater rate of malignancy had been seen in FN/SFN rather than AUS/FLUS 
category in several of the aforementioned studies.(9, 12, 13)  It is noteworthy to mention that 
these previous published studies were conducted prior to the introduction of NIFTP terminology. 
It is unclear if some of the specimens could actually be recategorized as NIFTP and therefore the 
malignant rate for each indeterminate category may be altered. Nonetheless, many factors may 
attribute to the variation in malignant rate, i.e. prevalence of malignant pediatric thyroid nodules, 
diagnostic thresholds for assessing cytologic and/or histologic specimens. It is crucial for 
pathologists, endocrinologists, and surgeons to have a clear understanding of practice patterns in 
their own institutions in order to provide an appropriate management of pediatric thyroid 
nodules.  
This article is protected by copyright. All rights reserved.
9 
 
A couple of the aforementioned studies specified types of malignancies on the subsequent 
resections specimens. In this regard, Smith et al observed mainly follicular variants of PTC, 
followed by conventional PTC and follicular carcinoma.(9) Partyka et al saw almost even 
number of conventional and follicular variant of PTC.(13) However, the malignancies seen in 
our study included mainly conventional PTC and a subset of follicular variant of PTC. None of 
the studies encountered other variants of PTC, i.e. diffuse sclerosing variant, previously reported 
by others.(10)  
In the current study, several patients with FLUS nodules underwent total thyroidectomies which 
revealed benign nodular hyperplasia. Clinically, these patients had multinodular goiter and at 
least one of the nodules exhibited continuous growth. Total thyroidectomy approach was chosen 
by the patient’s parents. In this regard, public awareness on increased risk of malignancy in 
pediatric thyroid nodules may have an influence in the decision making. Molecular testing could 
be used as an adjunct to FNA for further stratification of pediatric indeterminate nodules. It has 
been reported that the detection of a molecular genetic abnormality fully correlated with 
malignancy and the authors pointed out that the molecular studies would change the management 
in 5% of the AUS/FLUS cases and 25% of the FN/SFN cases in terms of expediting surgery and 
decreasing the need for repeat FNA.(15). However, molecular test has not been routinely utilized 
in the preoperative assessment of pediatric thyroid nodules in our institution. A few FLUS 
nodules received concurrent Afirma testing and the results did not always correlate well with the 
follow-up histology diagnoses. Our overall findings on the limited case cohort suggest that 
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Afirma testing may be helpful to avoid unnecessary surgery in some patients with thyroid 
nodules categorized into AUS/FLUS category, while pediatric thyroid nodules categorized as 
FN/SFN and SFM may be managed with surgery without preoperative Afirma testing. 
In conclusion, based on a limited study cohort, indeterminate pediatric thyroid nodules have a 
higher malignant rate compared with that of adult, particularly for FLUS and SFM categories. 
Furthermore, NIFTP appears to be rare in the pediatric population. 
References 
1. Rossi ED, Martini M, Cenci T, Capodimonti S, Larocca LM. The role of thyroid FNA 
cytology in pediatric malignant lesions: An overview of the literature. Cancer Cytopathol. 
2017;125(8):594-603. 
2. Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, et al. 
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. 
Thyroid. 2015;25(7):716-59. 
3. Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 
2009;19(11):1159-65. 
4. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, et al. 
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A 
Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 2016;2(8):1023-9. 
This article is protected by copyright. All rights reserved.
11 
 
5. Lai SW, Roberts DJ, Rabi DM, Winston KY. Diagnostic accuracy of fine needle 
aspiration biopsy for detection of malignancy in pediatric thyroid nodules: protocol for a 
systematic review and meta-analysis. Syst Rev. 2015;4:120. 
6. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. 
Thyroid. 2017;27(11):1341-6. 
7. Rossi ED, Mehrotra S, Kilic AI, Toslak IE, Lim-Dunham J, Martini M, et al. 
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age 
group. Cancer Cytopathol. 2018;126(1):27-35. 
8. Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, et al. A 
standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in 
adults. J Clin Endocrinol Metab. 2013;98(8):3238-45. 
9. Smith M, Pantanowitz L, Khalbuss WE, Benkovich VA, Monaco SE. Indeterminate 
pediatric thyroid fine needle aspirations: a study of 68 cases. Acta cytologica. 2013;57(4):341-8. 
10. Rossi ED, Straccia P, Martini M, Revelli L, Lombardi CP, Pontecorvi A, et al. The role 
of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience. 
Cancer Cytopathol. 2014;122(5):359-67. 
11. Lale SA, Morgenstern NN, Chiara S, Wasserman P. Fine needle aspiration of thyroid 
nodules in the pediatric population: a 12-year cyto-histological correlation experience at North 
Shore-Long Island Jewish Health System. Diagn Cytopathol. 2015;43(8):598-604. 
This article is protected by copyright. All rights reserved.
12 
 
12. Norlen O, Charlton A, Sarkis LM, Henwood T, Shun A, Gill AJ, et al. Risk of 
malignancy for each Bethesda class in pediatric thyroid nodules. J Pediatr Surg. 
2015;50(7):1147-9. 
13. Partyka KL, Huang EC, Cramer HM, Chen S, Wu HH. Histologic and clinical follow-up 
of thyroid fine-needle aspirates in pediatric patients. Cancer Cytopathol. 2016;124(7):467-71. 
14. Pantola C, Kala S, Khan L, Pantola S, Singh M, Verma S. Cytological diagnosis of 
pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid 
Cytopathology. J Cytol. 2016;33(4):220-3. 
15. Monaco SE, Pantanowitz L, Khalbuss WE, Benkovich VA, Ozolek J, Nikiforova MN, et 
al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. 
Cancer Cytopathol. 2012;120(5):342-50. 
  
Legends: 
Figure 1. Follicular lesion of undetermined significance case 
A. Disorganized follicular epithelial groups, mild nuclear enlargement and dense colloid in 
the background (Diff-Quik stain, 100x).  
B. Cytological atypia with nuclear enlargement, chromatin clearing, and nuclear membrane 
folds (Papanicolaou stain, 400x).   
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C. Follow-up surgical specimen showing papillary thyroid carcinoma, conventional type, 
with papillary projections and psammoma bodies. (H&E stain, 40x).  
D. Nuclear features of classical papillary thyroid carcinoma, i.e. powdery chromatin, 
intranuclear grooves and pseudoinclusion (H&E stain, 400x).  
 
Figure 2. Suspicious for follicular neoplasm case  
A. Hypercellular sample with microfollicular pattern (Diff-Quik stain, 100x). 
B. Nuclear enlargement with prominent nucleoli and oncocytic cytoplasm (Papanicolaou 
stain, 400x). 
C. Follow up surgical excision demonstrating Papillary thyroid carcinoma with follicular 
growth pattern lacking well defined capsule in a lymphocytic thyroiditis background. 
(H&E stain, 40x).  
D. Nuclear features of papillary thyroid carcinoma are evident. Please note the psammoma 
bodies, which also excludes this tumor from NIFTP category.  (H&E stain, 400x). 
 
Figure 3. Suspicious for malignancy case 
A. ThinPrep slide demonstrating cellular aspirate showing fragments of highly atypical 
follicular epithelial cells (Papanicolaou stain, 100x). 
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B. The group of cells with nuclear size variation, irregular nuclear outlines, nuclear grooves 
and occasional nucleoli (Papanicolaou stain, 400x).  
C. Surgical excision sample demonstrating conventional papillary thyroid carcinoma growth 
pattern. (H&E stain, 40x). 
D. High magnification showing classical nuclear features of papillary thyroid carcinoma 
with grooves and intranuclear inclusion (H&E, 400x).   
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Table 1. Cytologic-histologic correlation in pediatric indeterminate thyroid nodules 
Category                                       Histologic          Diagnoses Total 
NH LT FA HCA PTC 
FLUS 7 1 8 1 8 25 
SFN - - 8 - 2 10 
SFM - - - 1 5 6 
Total 7 1 16 2 15 41 
 
FLUS: Follicular lesion of undetermined significance 
SFN: Suspicious for follicular neoplasm 
SFM: Suspicious for malignancy 
NH: Nodular hyperplasia 
LT: Lymphocytic thyroiditis 
FA: Follicular adenoma 
HCA: Hurthle cell carcinoma 
PTC: Papillary thyroid carcinoma 
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Table 2. Rate of histology-confirmed malignancy (%) in pediatric indeterminate thyroids from 
different institutions 
Studies Current Gupta Smith Rossi Lale Norlen Partyka Pantola 
Year present 2013 2013 2014 2015 2015 2016 2016 
Categories 






2/9 (22) 4/14 
(29) 
1/12 (8) 








4/7 (57) 1/10 
(10) 














 AUS/FLUS: Atypia of undetermined significance/Follicular lesion of undetermined significance 
FN/SFN: Follicular neoplasm/Suspicious for follicular neoplasm 
SFM: Suspicious for malignancy 
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Table 1. Cytologic-histologic correlation in pediatric indeterminate thyroid nodules 
Category                                       Histologic          Diagnoses Total 
NH LT FA HCA PTC 
FLUS 7 1 8 1 8 25 
SFN - - 8 - 2 10 
SFM - - - 1 5 6 
Total 7 1 16 2 15 41 
 
FLUS: Follicular lesion of undetermined significance 
SFN: Suspicious for follicular neoplasm 
SFM: Suspicious for malignancy 
NH: Nodular hyperplasia 
LT: Lymphocytic thyroiditis 
FA: Follicular adenoma 
HCA: Hurthle cell carcinoma 
PTC: Papillary thyroid carcinoma 
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Table 2. Rate of histology-confirmed malignancy (%) in pediatric indeterminate thyroids from different institutions 
Studies Current Gupta Smith Rossi Lale Norlen Partyka Pantola 
Year present 2013 2013 2014 2015 2015 2016 2016 
Categories 
AUS/FLUS 9/25 (36) 4/10 (40) 7/25 (28) - 2/4 (50) 2/9 (22) 4/14 (29) 1/12 (8) 
FN/SFN 2/10 (20) 6/6 (100) 11/19 (58) - 7/18 (39) 4/4 (100) 4/7 (57) 1/10 (10) 
SFM 6/6 (100) 4/10 (100) 6/6 (100) 9/11 (82) 4/4 (100) 3/3 (100) 3/3 (100) 2/2 (100) 
 AUS/FLUS: Atypia of undetermined significance/Follicular lesion of undetermined significance 
FN/SFN: Follicular neoplasm/Suspicious for follicular neoplasm 
SFM: Suspicious for malignancy 
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